Zhanping Wu

Vivo Capital, Llc

Assets Managed

$1.203B

Holdings

Last Quarter

2026 - Q1

Filed Date

1d ago

Growth Rate

-22.24%(2Q avg: 1.13%)

Sustained Growth

0 quarters

Portfolio positions

This chart displays the top 10 holdings in Vivo Capital, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 46 positions.

Assets under management

The assets under management (AUM) of Vivo Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 1.203B in assets, with a quarterly growth rate of -22.24% and a 2-quarter average growth rate of 1.13%. The portfolio is managed by Zhanping Wu, and others.

Portfolio holdings

Investment	Portfolio %	Reported Value	Recent Activity
ERAS Erasca Inc Recent Activity Increased 31.04%	16.35%	$196.611M 12.151M shares@ $16.18 avg price	Increased 31.04%
PRAX Praxis Precision Medicines I Recent Activity Increased 3.05%	9.08%	$109.189M 338,895 shares@ $322.19 avg price	Increased 3.05%
TERN Terns Pharmaceuticals Inc Recent Activity Decreased -75.04%	5.85%	$70.351M 1.334M shares@ $52.73 avg price	Decreased -75.04%
TRVI Trevi Therapeutics Inc Recent Activity	5.06%	$60.779M 5.095M shares@ $11.93 avg price
DBVT Dbv Technologies Sa-spon Adr Recent Activity Increased 8.37%	4.64%	$55.726M 2.668M shares@ $20.89 avg price	Increased 8.37%
CMPX Compass Therapeutics Inc Recent Activity	4.2%	$50.496M 9.545M shares@ $5.29 avg price
TNGX Tango Therapeutics Inc Recent Activity	3.75%	$45.078M 2.155M shares@ $20.93 avg price
SABS Sab Biotherapeutics Inc Recent Activity	3.64%	$43.739M 11.42M shares@ $3.83 avg price
CRVS Corvus Pharmaceuticals Inc Recent Activity Increased 25.57%	3.42%	$41.049M 2.806M shares@ $14.63 avg price	Increased 25.57%
DRUG Bright Minds Biosciences Inc Recent Activity Increased 11.08%	3.38%	$40.657M 557,172 shares@ $72.98 avg price	Increased 11.08%

1-10 of 46